×
About 1,171 results

ALLMedicine™ Lipoprotein (a) Center

Research & Reviews  575 results

Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and ...
https://doi.org/10.1093/eurjpc/zwaa063
European Journal of Preventive Cardiology; Welsh P, Welsh C et. al.

Feb 24th, 2021 - To investigate the population attributable fraction due to elevated lipoprotein (a) (Lp(a)) and the utility of measuring Lp(a) in cardiovascular disease (CVD) risk prediction. In 413 734 participants from UK Biobank, associations of serum Lp(a) wi...

The management of heterozygous familial hypercholesterolaemia with high lipoprotein (a)...
https://doi.org/10.1177/2047487320905727
European Journal of Preventive Cardiology; Dal Pino B, Bigazzi F et. al.

Feb 21st, 2021 - The management of heterozygous familial hypercholesterolaemia with high lipoprotein (a) and statin intolerance. The guidelines a mirage?|2021|Dal Pino B,Bigazzi F,Sbrana F,Sampietro T,|

Lipoprotein (a) and coronary artery calcification: prospective study assessing interact...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853621
Metabolism: Clinical and Experimental; Ong KL, McClelland RL et. al.

Jan 9th, 2021 - Elevated plasma lipoprotein (a) [Lp(a)] and coronary artery calcification (CAC) are established cardiovascular risk factors that correlate with each other. We hypothesized that other cardiovascular risk factors could affect their relationship. We ...

Cardiovascular events in patients with familial hypercholesterolemia and hyperlipoprote...
https://doi.org/10.1002/jca.21872
Journal of Clinical Apheresis REFERENCES; Mickiewicz A, Marlega J et. al.

Jan 2nd, 2021 - Lipoprotein apheresis (LA) is a safe method of reducing atherogenic lipoproteins and improving cardiovascular (CV) outcomes. We aimed to assess the reductions in low-density lipoprotein cholesterol (LDL-C) and lipoprotein (a) [Lp(a)] levels in pat...

The association between lipoprotein (a) and carotid atherosclerosis in patients with ty...
https://doi.org/10.1016/j.diabres.2020.108622
Diabetes Research and Clinical Practice; Jun JE, Kang H et. al.

Dec 14th, 2020 - Lipoprotein (a) [Lp(a)] has been considered a determinant of residual cardiovascular risk. We aimed to investigate associations between serum Lp(a) levels and carotid atherosclerosis. This cross-sectional study included 662 type 2 diabetic patient...

see more →

Clinicaltrials.gov  587 results

Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and ...
https://doi.org/10.1093/eurjpc/zwaa063
European Journal of Preventive Cardiology; Welsh P, Welsh C et. al.

Feb 24th, 2021 - To investigate the population attributable fraction due to elevated lipoprotein (a) (Lp(a)) and the utility of measuring Lp(a) in cardiovascular disease (CVD) risk prediction. In 413 734 participants from UK Biobank, associations of serum Lp(a) wi...

The management of heterozygous familial hypercholesterolaemia with high lipoprotein (a)...
https://doi.org/10.1177/2047487320905727
European Journal of Preventive Cardiology; Dal Pino B, Bigazzi F et. al.

Feb 21st, 2021 - The management of heterozygous familial hypercholesterolaemia with high lipoprotein (a) and statin intolerance. The guidelines a mirage?|2021|Dal Pino B,Bigazzi F,Sbrana F,Sampietro T,|

Lipoprotein (a) and coronary artery calcification: prospective study assessing interact...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853621
Metabolism: Clinical and Experimental; Ong KL, McClelland RL et. al.

Jan 9th, 2021 - Elevated plasma lipoprotein (a) [Lp(a)] and coronary artery calcification (CAC) are established cardiovascular risk factors that correlate with each other. We hypothesized that other cardiovascular risk factors could affect their relationship. We ...

Cardiovascular events in patients with familial hypercholesterolemia and hyperlipoprote...
https://doi.org/10.1002/jca.21872
Journal of Clinical Apheresis REFERENCES; Mickiewicz A, Marlega J et. al.

Jan 2nd, 2021 - Lipoprotein apheresis (LA) is a safe method of reducing atherogenic lipoproteins and improving cardiovascular (CV) outcomes. We aimed to assess the reductions in low-density lipoprotein cholesterol (LDL-C) and lipoprotein (a) [Lp(a)] levels in pat...

The association between lipoprotein (a) and carotid atherosclerosis in patients with ty...
https://doi.org/10.1016/j.diabres.2020.108622
Diabetes Research and Clinical Practice; Jun JE, Kang H et. al.

Dec 14th, 2020 - Lipoprotein (a) [Lp(a)] has been considered a determinant of residual cardiovascular risk. We aimed to investigate associations between serum Lp(a) levels and carotid atherosclerosis. This cross-sectional study included 662 type 2 diabetic patient...

see more →

News  9 results

Novartis aims to pump up cardio business with Ionis deal
https://www.reuters.com/article/us-novartis-ionis-pharma-licensing/novartis-aims-to-pump-up-cardio-business-with-ionis-deal-idUSKCN1QE0KT

Feb 25th, 2019 - ZURICH (Reuters) - Novartis will pay $150 million to Ionis Pharmaceuticals to license an RNA-targeting cardiovascular drug as the Swiss company aims to bolster its range of heart disease treatments that now includes the blockbuster Entresto. FILE ...

Niacin's effect on cardiovascular risk: Have we finally learned our lesson?
https://www.mdedge.com/ccjm/article/96071/cardiology/niacins-effect-cardiovascular-risk-have-we-finally-learned-our-lesson?channel=194
Stephen J. Nicholls, MBBS, PhD

May 1st, 2014 - Randomized controlled trials have unequivocally shown that lowering levels of low-density lipoprotein cholesterol (LDL-C) with statins reduces the rate of cardiovascular events. 1–3 Yet many patients still have heart attacks even though they are on.

Lp(a) Gene Variant Associated With Aortic Stenosis
https://www.medscape.com/viewarticle/778878

Feb 5th, 2013 - MONTREAL, Quebec — An international consortium has identified a variation in the gene coding for lipoprotein (a) (Lp[a]), which appears to be strongly associated with aortic-valve calcification [1]. People carrying this single nucleotide polymorph...

Lp(a) Does Predict Risk in Blacks, New ARIC Data Show
https://www.medscape.com/viewarticle/754584

Nov 30th, 2011 - December 1, 2011 (Houston, Texas) — Elevated levels of lipoprotein (a) [Lp(a)] are associated with cardiovascular events in African Americans, and the risk is comparable to that seen in whites, a new analysis of the Atherosclerosis Risk in Communi...

Lp(a) Is a Causal Factor for CVD, But a Modest One
https://www.medscape.com/viewarticle/706265

Jul 20th, 2009 - July 21, 2009 (Cambridge, United Kingdom) — A new pooled analysis of 36 prospective studies shows there is a continuous association between blood concentration of lipoprotein (a)--Lp(a)--and the risk of MI and stroke [1]. Importantly, this associa...

see more →